Stocks · News reference

Evercore ISI Group Initiates Coverage On Apnimed with Outperform Rating

Aug 25, 2026, 10:54 AMBenzinga Newsdesk

Evercore ISI Group analyst Umer Raffat initiates coverage on Apnimed (NASDAQ:APMD) with a Outperform rating.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 25, 2026, 3:18 PMBenzinga Newsdesk
LifeSci Capital Initiates Coverage On Apnimed with Outperform Rating, Announces Price Target of $50
LifeSci Capital analyst Francois Brisebois initiates coverage on Apnimed (NASDAQ:APMD) with a Outperform rating and announces Price Target of $50.
Read original at benzinga
APMD
BenzingaAug 25, 2026, 12:10 PMAvi Kapoor
This Agomab Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Analysts change outlook on top names. See all rating changes, including upgrades/downgrades/initiations. Coverage initiated on various stocks.
Read original at benzinga
AGMB APMD JBTM JMKE KDK
BenzingaAug 25, 2026, 11:04 AMBenzinga Newsdesk
Cantor Fitzgerald Initiates Coverage On Apnimed with Overweight Rating, Announces Price Target of $60
Cantor Fitzgerald analyst Josh Schimmer initiates coverage on Apnimed (NASDAQ:APMD) with a Overweight rating and announces Price Target of $60.
Read original at benzinga
APMD